ANGLE plc
(OTC: ANPCY)
|
3:43 PM UTC, 05/31/24 | |||
---|---|---|---|---|
Last: $2.39 | Change: +0.27 | %Change: +12.74% | Volume: 600 |
Open: | $ 2.06 | Volume: | 600 | |
---|---|---|---|---|
High: | $ 2.39 | Yield(%) | 0.00 | |
Low: | $ 2.06 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 59.34M | |
EPS ($) | n/a | Shares Out: | 32.25M |
% Price Change (last 4 weeks): | -20.12 |
---|---|
% Price Change (last 13 weeks): | 16.04 |
% Price Change (last 26 weeks): | 21.32 |
% Price Change (last 52 weeks): | 13.60 |
% Price Change (year to date): | 22.83 |
Return on Equity (%): | -64.64 |
---|---|
Return on Assets (%): | -50.18 |
Return on Invested Capital (%): | -44.59 |
Gross Profit Margin (%): | -513.22 |
---|---|
Net Profit Margin (%): | -920.95 |
Operating Profit Margin (%): | -913.86 |
50-day Moving Average: | $0.70 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 687 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $4.00 |
52-wk low: | $1.13 |
Bid: | $n/a |
Ask: | $n/a |
ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.
|
ANGLE plc
The Surrey Research Park 10 Nugent Road Guildford SU GU2 7AF Phone: 44.1483.343434 Fax: n/a http://www.angleplc.com |
Earnings (1year) ($): | -0.96 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 1.12 |
Cash Flow ($): | -0.87 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 14.38 |
Price/Book (x): | 1.34 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 4.95 |
---|---|
Current Ratio (x): | 5.38 |
LT Debt/Equity (x): | 17.02 |
Total Debt/Equity (x): | 19.85 |